Value-based Oncology Leader Improving Access to Cutting-Edge Therapies CERRITOS, Calif., Sept. 29, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), today announces the enrollment of two of its patients as the first and second patients dosed in the United States in a phase 3
Expands board to 9 members with deep healthcare management and investment experience CERRITOS, Calif., Sept. 22, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based community oncology groups in the United States, today announced the appointment of
CERRITOS, Calif., Sept. 15, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that its Chief Executive Officer, Brad Hively, will participate on the “Next Frontier - Value Based Care for
Publicly traded leader in value-based oncology care raises standards in patient safety CERRITOS, Calif., Sept. 12, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based community oncology groups in the United States, announced today an important step in
CERRITOS, Calif., Aug. 22, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based community oncology groups in the United States, and Blue Note Therapeutics, a prescription digital therapeutics (PDT) company dedicated to easing the burden of cancer and
CERRITOS, Calif., Aug. 16, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based community oncology groups in the United States, today announced that its Chief Executive Officer, Brad Hively, and its Chief Financial Officer, Mihir Shah, will participate
CERRITOS, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based community oncology groups in the United States, today reported financial results for its second quarter ended June 30, 2022.
Investment to accelerate Company’s expansion into new markets, bringing high-quality, value-based care to more patients CERRITOS, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based community oncology groups in the United States,
Las Vegas-based practice of Dr. Nutan Parikh to join TOI CERRITOS, Calif., July 26, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based community oncology groups in the United States, announced the acquisition of the practice of Dr. Nutan Parikh.
CERRITOS, Calif., July 19, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC (“TOI”) (NASDAQ: TOI) today announced that the company will release its second quarter results after the market close on Tuesday August 9, 2022, to be followed by a conference call the same day 5:00 p.m. (Eastern Time).